Literature DB >> 24523408

Tudor-SN, a novel coactivator of peroxisome proliferator-activated receptor γ protein, is essential for adipogenesis.

Zhongchao Duan1, Xiujuan Zhao, Xiao Fu, Chao Su, Lingbiao Xin, Juha Saarikettu, Xi Yang, Zhi Yao, Olli Silvennoinen, Minxin Wei, Jie Yang.   

Abstract

Adipogenesis, in which mesenchymal precursor cells differentiate into mature adipocytes, is a well orchestrated process. In the present study we identified Tudor-SN as a novel co-activator of the transcription factor peroxisome proliferator-activated receptor γ (PPARγ). We provide the first evidence that Tudor-SN and PPARγ exist in the same complex. Both are up-regulated by the early factor C/EBPβ during adipogenesis and significantly influence the regulation of PPARγ target genes in both 3T3-L1 pre-adipocyte and mouse embryonic fibroblasts (MEF) upon exposure to a mixture of hormonal mixture. Moreover, aP2-PPARγ response element (PPRE) interacts with both PPARγ and Tudor-SN, and the gene transcriptional activation of PPRE-luc is enhanced by ectopic expression of Tudor-SN. Deletion of Tudor-SN protein (MEF-KO) affects but does not completely abolish the association of PPARγ and aP2-PPRE. Loss-of-function studies further verified that Tudor-SN is required for adipogenesis, as deletion of Tudor-SN (MEF-KO) impairs dexamethasone, 3-isobutyl-1-methylxanthine, and insulin (DMI)-induced adipocyte differentiation and the expression of PPARγ target genes, such as aP2 and adipsin. Furthermore, H3 acetylation levels were lower in MEF-KO than MEF-WT. Both HDAC1 and HDAC3 are stably associated with PPARγ in MEF-KO, whereas only a small amount of association was observed in MEF-WT after 5 days of treatment during adipogenesis. PPARγ requires various co-activators or co-repressors, which may dynamically associate with and regulate the higher order chromatin remodeling of the promoter region of PPARγ-bound target genes; Tudor-SN is likely one of these co-activators.

Entities:  

Keywords:  Adipogenesis; C/EBP Transcription Factor; C/EBPβ; HDAC; Histone Deacetylase; Histone Modification; PPARγ; Peroxisome Proliferator-activated Receptor (PPAR); Tudor-SN

Mesh:

Substances:

Year:  2014        PMID: 24523408      PMCID: PMC3961662          DOI: 10.1074/jbc.M113.523456

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease.

Authors:  Seng Hui Low; Shivakumar Vasanth; Claire H Larson; Sambuddho Mukherjee; Nikunj Sharma; Michael T Kinter; Michelle E Kane; Tomoko Obara; Thomas Weimbs
Journal:  Dev Cell       Date:  2006-01       Impact factor: 12.270

Review 2.  Adipocytes as regulators of energy balance and glucose homeostasis.

Authors:  Evan D Rosen; Bruce M Spiegelman
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 3.  Transcriptional control of adipocyte formation.

Authors:  Stephen R Farmer
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

4.  Overexpression of SND p102, a rat homologue of p100 coactivator, promotes the secretion of lipoprotein phospholipids in primary hepatocytes.

Authors:  Lourdes Palacios; Begoña Ochoa; María José Gómez-Lechón; José Vicente Castell; Olatz Fresnedo
Journal:  Biochim Biophys Acta       Date:  2006-05-19

5.  Transcription. A growing coactivator network.

Authors:  R Janknecht; T Hunter
Journal:  Nature       Date:  1996-09-05       Impact factor: 49.962

6.  The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb.

Authors:  A B Dash; F C Orrico; S A Ness
Journal:  Genes Dev       Date:  1996-08-01       Impact factor: 11.361

7.  NF-Y and Sp1 are involved in transcriptional regulation of rat SND p102 gene.

Authors:  Lorena Rodríguez; Begoña Ochoa; María José Martínez
Journal:  Biochem Biophys Res Commun       Date:  2007-02-28       Impact factor: 3.575

8.  The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6.

Authors:  Tuuli Välineva; Jie Yang; Riitta Palovuori; Olli Silvennoinen
Journal:  J Biol Chem       Date:  2005-02-04       Impact factor: 5.157

9.  Dynamics of fat cell turnover in humans.

Authors:  Kirsty L Spalding; Erik Arner; Pål O Westermark; Samuel Bernard; Bruce A Buchholz; Olaf Bergmann; Lennart Blomqvist; Johan Hoffstedt; Erik Näslund; Tom Britton; Hernan Concha; Moustapha Hassan; Mikael Rydén; Jonas Frisén; Peter Arner
Journal:  Nature       Date:  2008-05-04       Impact factor: 49.962

Review 10.  Fat and beyond: the diverse biology of PPARgamma.

Authors:  Peter Tontonoz; Bruce M Spiegelman
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

View more
  9 in total

1.  SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma.

Authors:  Xiaoteng Cui; Chunyan Zhao; Xuyang Yao; Baoxin Qian; Chao Su; Yuanyuan Ren; Zhi Yao; Xingjie Gao; Jie Yang
Journal:  RNA Biol       Date:  2018-10-25       Impact factor: 4.652

Review 2.  Tudor staphylococcal nuclease: biochemistry and functions.

Authors:  Emilio Gutierrez-Beltran; Tatiana V Denisenko; Boris Zhivotovsky; Peter V Bozhkov
Journal:  Cell Death Differ       Date:  2016-09-09       Impact factor: 15.828

3.  Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress.

Authors:  Xiao Fu; Chunyan Zhang; Hao Meng; Kai Zhang; Lei Shi; Cheng Cao; Ye Wang; Chao Su; Lingbiao Xin; Yuanyuan Ren; Wei Zhang; Xiaoming Sun; Lin Ge; Olli Silvennoinen; Zhi Yao; Xi Yang; Jie Yang
Journal:  Cell Death Differ       Date:  2018-02-19       Impact factor: 15.828

4.  SREBP-2-driven transcriptional activation of human SND1 oncogene.

Authors:  Sandra Armengol; Enara Arretxe; Leire Enzunza; Irati Llorente; Unai Mendibil; Hiart Navarro-Imaz; Begoña Ochoa; Yolanda Chico; María José Martínez
Journal:  Oncotarget       Date:  2017-11-21

5.  The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma.

Authors:  Saranya Chidambaranathan-Reghupaty; Rachel Mendoza; Paul B Fisher; Devanand Sarkar
Journal:  Hepatoma Res       Date:  2018-07-10

6.  Mitochondrion-Localized SND1 Promotes Mitophagy and Liver Cancer Progression Through PGAM5.

Authors:  Shiwei Liang; Chuxu Zhu; Caixia Suo; Haoran Wei; Yingxuan Yu; Xuemei Gu; Liang Chen; Mengqiu Yuan; Shengqi Shen; Shiting Li; Linchong Sun; Ping Gao
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

7.  The promoter of cell growth- and RNA protection-associated SND1 gene is activated by endoplasmic reticulum stress in human hepatoma cells.

Authors:  Sandra Armengol; Enara Arretxe; Leire Enzunza; Sarai Mula; Begoña Ochoa; Yolanda Chico; María José Martínez
Journal:  BMC Biochem       Date:  2014-12-11       Impact factor: 4.059

8.  Profiling of promoter occupancy by the SND1 transcriptional coactivator identifies downstream glycerolipid metabolic genes involved in TNFα response in human hepatoma cells.

Authors:  Enara Arretxe; Sandra Armengol; Sarai Mula; Yolanda Chico; Begoña Ochoa; María José Martínez
Journal:  Nucleic Acids Res       Date:  2015-08-31       Impact factor: 16.971

9.  Impact of hepatocyte-specific deletion of staphylococcal nuclease and tudor domain containing 1 (SND1) on liver insulin resistance and acute liver failure of mice.

Authors:  Chunyan Zhao; Xiaoteng Cui; Yan Zhao; Baoxin Qian; Nan Zhang; Lingbiao Xin; Chuanbo Ha; Jie Yang; Xinting Wang; Xingjie Gao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.